linsidomine has been researched along with metallothionein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Kang, YJ; Klein, JB | 1 |
| Ebadi, M; Sharma, SK | 1 |
| Ebadi, M; Sharma, S | 1 |
3 other study(ies) available for linsidomine and metallothionein
| Article | Year |
|---|---|
Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage.
Topics: Antioxidants; Cell-Free System; DNA Damage; Dose-Response Relationship, Drug; Lipid Peroxides; Lipoproteins; Lipoproteins, LDL; Metallothionein; Molsidomine; Nitrates; Nitrogen; Oxygen; Plasmids; Temperature; Thiobarbituric Acid Reactive Substances; Time Factors | 2000 |
Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
Topics: alpha-Synuclein; Animals; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Corpus Striatum; Deoxyadenosines; Dopamine; Gene Expression Regulation; Humans; Lipid Peroxidation; Metallothionein; Metals; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Molsidomine; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Oxidative Stress; Selegiline; Stem Cells; Synucleins; Transcriptional Activation | 2003 |
Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Coenzymes; Dopamine; Enzyme Activation; Lipid Peroxidation; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molsidomine; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Ubiquinone | 2006 |